Effects of histone deacetylase inhibitors on rat mesangial cells (Q43239274)

17 November 2017

Effects of histone deacetylase inhibitors on rat mesangial cells (English)

1 reference

17 November 2017

1 reference

Ilya Freidkin

1

1 reference

17 November 2017

Michal Herman

2

1 reference

17 November 2017

Ana Tobar

3

1 reference

17 November 2017

Avry Chagnac

4

1 reference

17 November 2017

Yaacov Ori

5

1 reference

17 November 2017

Asher Korzets

6

1 reference

17 November 2017

Uzi Gafter

7

1 reference

17 November 2017

18 November 2009

1 reference

American Journal of Physiology - Renal Physiology

17 November 2017

1 reference

17 November 2017

298

1 reference

17 November 2017

2

1 reference

17 November 2017

F426-34

1 reference

Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors

17 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

D-valine as a selective agent for normal human and rodent epithelial cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Histone deacetylase inhibitors and cancer: from cell biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Differential effects of simvastatin on mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

The glomerular response to injury: progression or resolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Autocrine secretion of transforming growth factor-beta in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Histone deacetylase inhibitors: a novel class of therapeutic agents in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

A phase I trial of depsipeptide (FR901228) in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Cell cycle and glomerular disease: a minireview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Quantification of renal pathology by image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

The balance between acetylation and deacetylation controls Smad7 stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Regulation of smooth muscle alpha-actin expression and hypertrophy in cultured mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

SMP-534 inhibits TGF-beta-induced ECM production in fibroblast cells and reduces mesangial matrix accumulation in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Down-regulation of histone deacetylases stimulates adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00107.2009

10.1152/AJPRENAL.00107.2009

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference